Possible involvement of Cyclic-GMP-dependent protein kinase on matrix metalloproteinase-2 expression in rat aortic smooth muscle cells

Molecular and Cellular Biochemistry

Volumn 368, Issue 1-2, 2012, Pages 27-35

  Dey, Nupur B ^a   Lincoln, Thomas M ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

DT 2; Matrix metalloproteinases 2; PKG; Transfection; Vascular smooth muscle cells

Indexed keywords

COMPLEMENTARY DNA; CYCLIC GMP DEPENDENT PROTEIN KINASE; DT 2; GELATINASE A; GELATINASE B; MESSENGER RNA; NITRIC OXIDE; PROTEIN INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; AORTIC SMOOTH MUSCLE CELL; ARTICLE; CELL MIGRATION; GENETIC TRANSFECTION; HEART MUSCLE CELL; IMMUNOCYTOCHEMISTRY; MALE; MOLECULAR CLONING; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RAT; ZYMOGRAPHY;

ANIMALS; AORTA; CELL MOVEMENT; CELL PROLIFERATION; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

RATTUS;

EID: 84864354356     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1339-2     Document Type: Article

References (31)

1. Schwartz SM, Campbell GR, Campbell JH (1986) Replication of SMC in vascular diseases. Circ Res 58:427-444
2. Ross R (1993) The pathogenesis of atherosclerosis, a perspective for the 1990s. Nature 362:801-809
3. Southgate KM, Davies M, Booth RFG, Newby AC (1992) Involvement of extracellular-matrix degrading metalloproteinase in rabbit aortic smooth muscle cell proliferation. Biochem J 288:93-99
4. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Pa-padopoulos N, Gluzband YA, Smith I, Weinstein C, Lakatta EG, Crow M (1994) Migration of vascular smooth muscle cells through a basement membrane barrier requires type IV collage-nase activity and is inhibited by cellular differentiation. Circ Res 75:41-54 (Pubitemid 24187734)
5. Cornwell TL, Soff GA, Traynor AE, Lincoln TM (1994) Regula-tion of the expression of c GMP dependent protein kinase by cell density in vascular smooth muscle cells. J Vasc Res 31:330-337 (Pubitemid 24358732)
6. Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW (1996) Regulation of vascular smooth muscle cell migration and pro-liferation in vitro and in injured arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 16:28-33 (Pubitemid 26026928)
7. Bendeck MP, Irvin I, Reidy MA (1996) Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not noontime thickening after arterial injury. Circ Res 8(1):33-43
8. Garg UC, Hassid A (1989) Nitric oxide generating vasodilators and 8-Bromo-cyclic guanosine monophosphate inhibits mito-genesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774-1777 (Pubitemid 19124139)
9. Nakaki T, Nakayama M, Kato R (1990) Inhibition ofnitric oxide and nitric oxide producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol 189:347-353
10. Cayatte AJ, Palacino JJ, Horten K, Cohen RA (1994) Chronic inhibition of nitric oxide production accelerates neointima for-mation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol 14:753-759
11. Dey NB, Boerth NJ, Murphy- Ullrich, Chang PL, Prince CW, Lincoln TM (1998) Cyclic GMP dependent protein kinase inhibits osteopontin and thrombospondin production in rat aortic smooth muscle cells. Circ Res 82:139-146 (Pubitemid 28080096)
12. Anderson PG, Boerth NJ, Liu M, Mc Namara DB, Cornwell TL, Lincoln TM (2000) Cyclic GMP-dependent protein kinase expression in coronary arterial smooth muscle in response to bal-loon catheter injury. Arterioscler Thromb Vasc Biol 20:2192-2197
13. Benedick MP, Irvine C, Reidy MA (1996) Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointima thickening after arterial injury. Circ Res 78:38-43 (Pubitemid 26004118)
14. Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW (1996) Regulation of vascular smooth muscle cell migration and pro-liferation in vitro and in injured arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 16:28-33 (Pubitemid 26026928)
15. Forough R, Koyama N, Hassenstab D, Lea H, Clowes M, Nikkari ST, Clowes AW (1996) Over expression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell function in vitro and in vivo. Circ Res 79(4):812-820 (Pubitemid 26317829)
16. George SJ, Johnson JL, Angelini GD, Newby AC, Baker AH (1998) Adenovirus mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell muscle migration and neontima formation in human saphenous vein. Hum Gene Ther 9(6):867-877 (Pubitemid 28197373)
17. Gurjar MV, Sharma RV, Bhalla RC (1999) e NOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterioscler Thromb Vasc Biol 19:2871-2877 (Pubitemid 30029812)
18. Boerth NJ, Dey NB, Cornwell TL, Lincoln TM (1997) Cyclic GMP dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res 34(4):245-259 (Pubitemid 27292644)
19. Marti HP, Mc Neil L, Davies M, Martin J, Lovett DH (1993) Homology cloning of rat 72 KDa type IV collagenase: cytokine and second messenger inducibility in glomerular mesangial cells. Biochem J 291(pt.2):441-446 (Pubitemid 23127026)
20. Rajagopalon S, Meng P, Ramasamy S, Harrison DG, Galis Z (1996) Reactive oxygen species produced by macrophage-derived foam cells regulates the activity of vascular matrix metalloproteinase in vitro; implications for atherosclerotic plaque stability. J Clin Invest 98(11):2572-2579 (Pubitemid 26415078)
21. Renart J, Reiser J, Stark GR (1979) Transfer of protein from gel to diazobenzyloxymethyl paper and detection with antisera: a method for studying antibody specificity and antigen structure. Proc Natl Acad Sci USA 76(7):3116-3120 (Pubitemid 9233242)
22. Chiche JD, Schlutsmeyer SM, Bloch DB, de la Monte SM, Roberts JD Jr, Filippov G, Janssens SP, Rosenzweig A, Bloch KD (1998) Adenovirus mediated gene transfer of a c GMP-dependent protein kinase increases the sensitivity of vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/c GMP. J Biol Chem 273:34263-34271
23. Cornwell Tl, Lincoln TM (1989) Regulation of intracellular calcium levels in cultured vascular smooth muscle cells: reduc-tion of ca+ by atriopeptin and 8-bromo cyclic GMP id mediated by cyclic GMP-dependent protein kinase. J Biol Chem 264:1146-1155 (Pubitemid 19038105)
24. Dey NB, Foley KF, Lincoln TM, Dostmann WR (2005) Inhibi-tion of c GMP-dependent protein kinase reverses phenotypic modulation of vascular smoth muscle cells. J Cardiovasc Phar-macol 45(4):404-413 (Pubitemid 40627960)
25. Galis ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinase and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503 (Pubitemid 24379627)
26. Li Z, Li L, Zielke HR, Cheng L, Xiao R, Crow MT et al (1996) Increased Expression of 72 KD type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 148:121-128 (Pubitemid 26019650)
27. Lijnen HR, Soloway P, Collen D (1999) Tissue inhibitor of Matrix metalloproteinase-1 impairs arterial neointima formation after vascular injury in mice. Circ Res 85:1186-1191 (Pubitemid 30430624)
28. Baron AV, Frisdal E, Eddahibi S, Deprez I, Baker AH, Newby AC et al (2000) Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer or doxycycline aggravates pulmonary hypertension in rats. Circ Res 87:418-425
29. Wang S, Wu X, Lincoln TM, Ullrich JEM (2003) Expression of constitutively active c-GMP dependent protein kinase prevents glucose stimulation of thrombospondin-1 expression and TGF-α activity. Diabetes 52:2144-2150 (Pubitemid 36919810)
30. Chen KC, Wang YS, Hu CY, Chang LYC, Dai CY, Juo SHH (2011) Ox LDL up- regulates micro RNA-29b, leading to epige-netic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular disease. FASEB J 25:1718-1728
31. Dey NB, Busch JL, Francis SH, Corbin JD, Lincoln TM (2009) Cyclic GMP specifically suppresses Type-1α c GMP-dependent protein kinase expression by ubiquitination. Cell Signal 21(6):859-866